Marras C - Search Results

1

Risk of Parkinson's disease dementia related to level I MDS PD-MCI.

Hoogland J, Boel JA, de Bie RMA, Schmand BA, Geskus RB, Dalrymple-Alford JC, Marras C, Adler CH, Weintraub D, Junque C, Pedersen KF, Mollenhauer B, Goldman JG, Tröster AI, Burn DJ, Litvan I, Geurtsen GJ; MDS Study Group “Validation of Mild Cognitive Impairment in Parkinson Disease”. Hoogland J, et al. Among authors: marras c. Mov Disord. 2019 Mar;34(3):430-435. doi: 10.1002/mds.27617. Epub 2019 Jan 17. Mov Disord. 2019. PMID: 30653248

2

69-year-old man with gait disturbance and Parkinsonism.

Marras C, Lang AE, Ang LC, Zijlmans J, Wenning GK. Marras C, et al. Mov Disord. 2001 May;16(3):548-61. doi: 10.1002/mds.1082. Mov Disord. 2001. PMID: 11391758 No abstract available.

3

Quality of life in early Parkinson's disease: impact of dyskinesias and motor fluctuations.

Marras C, Lang A, Krahn M, Tomlinson G, Naglie G; Parkinson Study Group. Marras C, et al. Mov Disord. 2004 Jan;19(1):22-8. doi: 10.1002/mds.10642. Mov Disord. 2004. PMID: 14743356 Clinical Trial.

4

Smell identification ability in twin pairs discordant for Parkinson's disease.

Marras C, Goldman S, Smith A, Barney P, Aston D, Comyns K, Korell M, Langston JW, Ross GW, Tanner CM. Marras C, et al. Mov Disord. 2005 Jun;20(6):687-93. doi: 10.1002/mds.20389. Mov Disord. 2005. PMID: 15719425

5

Antipsychotic use in older adults with Parkinson's disease.

Marras C, Kopp A, Qiu F, Lang AE, Sykora K, Shulman KI, Rochon PA. Marras C, et al. Mov Disord. 2007 Feb 15;22(3):319-23. doi: 10.1002/mds.21192. Mov Disord. 2007. PMID: 17149718

6

Unilateral versus bilateral tasks in early asymmetric Parkinson's disease: differential effects on bradykinesia.

Kishore A, Espay AJ, Marras C, Al-Khairalla T, Arenovich T, Asante A, Miyasaki J, Lang AE. Kishore A, et al. Among authors: marras c. Mov Disord. 2007 Feb 15;22(3):328-33. doi: 10.1002/mds.21238. Mov Disord. 2007. PMID: 17216641

7

Is there seasonal variation in risk of Parkinson's disease?

Postuma RB, Wolfson C, Rajput A, Stoessl AJ, Martin WR, Suchowersky O, Chouinard S, Panisset M, Jog MS, Grimes DA, Marras C, Lang AE. Postuma RB, et al. Among authors: marras c. Mov Disord. 2007 Jun 15;22(8):1097-101. doi: 10.1002/mds.21272. Mov Disord. 2007. PMID: 17486603

8

A comparison of the mini mental state exam to the Montreal cognitive assessment in identifying cognitive deficits in Parkinson's disease.

Zadikoff C, Fox SH, Tang-Wai DF, Thomsen T, de Bie RM, Wadia P, Miyasaki J, Duff-Canning S, Lang AE, Marras C. Zadikoff C, et al. Among authors: marras c. Mov Disord. 2008 Jan 30;23(2):297-9. doi: 10.1002/mds.21837. Mov Disord. 2008. PMID: 18044697

9

Predictors of deterioration in health-related quality of life in Parkinson's disease: results from the DATATOP trial.

Marras C, McDermott MP, Rochon PA, Tanner CM, Naglie G, Lang AE; Parkinson Study Group DATATOP Investigators. Marras C, et al. Mov Disord. 2008 Apr 15;23(5):653-9; quiz 776. doi: 10.1002/mds.21853. Mov Disord. 2008. PMID: 18076084

10

A comparison of treatment thresholds in two large Parkinson's disease clinical trial cohorts.

Marras C, Lang AE, Eberly SW, Oakes D, Fahn S, Schwid SR, Hyson C, Shoulson I; Parkinson Study Group DATATOP and PRECEPT investigators. Marras C, et al. Mov Disord. 2009 Dec 15;24(16):2370-8. doi: 10.1002/mds.22828. Mov Disord. 2009. PMID: 19908310 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

502 results

Search Page

Filters